Laboratory Corp Q4 Adjusted EPS $3.30 Beats $3.28 Estimate, Sales $3.03B Beat $3.01B Estimate
Portfolio Pulse from Benzinga Newsdesk
Laboratory Corp (NYSE:LH) reported Q4 adjusted EPS of $3.30, surpassing the $3.28 estimate, and sales of $3.03B, exceeding the $3.01B estimate. This represents an 8.2% increase in earnings and a 3.53% increase in sales compared to the same period last year.
February 15, 2024 | 11:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Laboratory Corp reported a Q4 adjusted EPS of $3.30, beating estimates, and sales of $3.03B, also above expectations. Year-over-year, earnings increased by 8.2% and sales by 3.53%.
Beating both earnings and sales estimates typically has a positive impact on a company's stock price in the short term. The reported year-over-year growth in earnings and sales further strengthens the positive outlook for Laboratory Corp's stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100